Envoy Medical Inc. has announced the issuance of two new patents, enhancing its intellectual property holdings in the United States. The U.S. Patent & Trademark Office granted U.S. Patent No. 12,318,607, titled "Implantable Cochlear System with Integrated Components and Lead Characterization," and U.S. Patent No. 12,318,613, titled "Implantable Cochlear Implant System with Integrated Signal Analysis Functionality," both on June 3, 2025. These patents cover methods related to compensating for variability in a middle ear sensor and using external devices for signal analysis in fully implantable cochlear systems.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.